JPH10507743A - 薬剤投与のための方法と手段 - Google Patents
薬剤投与のための方法と手段Info
- Publication number
- JPH10507743A JPH10507743A JP8508010A JP50801095A JPH10507743A JP H10507743 A JPH10507743 A JP H10507743A JP 8508010 A JP8508010 A JP 8508010A JP 50801095 A JP50801095 A JP 50801095A JP H10507743 A JPH10507743 A JP H10507743A
- Authority
- JP
- Japan
- Prior art keywords
- prostaglandin
- optic disc
- drug
- eye
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 視神経乳頭とその周囲領域とに薬剤を送達する方法であって、 眼科的に許容可能な担体中の −前記視神経乳頭の治療のための有効量の薬剤と、 −前記視神経乳頭に対する前記薬剤の送達を増大させるための生理学上許容可能 なプロスタグランジン又はプロスタグランジン誘導体とに、 眼の表面を接触させることを含む前記方法。 2. 前記プロスタグランジン又はプロスタグランジン誘導体を含む組成物を、 前記薬剤を含む組成物の前に投与する請求項1に記載の方法。 3. 前記プロスタグランジン又はプロスタグランジン誘導体がFタイプである 請求項1又は2に記載の方法。 4. 前記プロスタグランジン又はプロスタグランジン誘導体がエステルである 請求項1から3のいずれか一項に記載の方法。 5. 眼科的に許容可能な担体中に視神経乳頭の治療のための有効量の薬剤を含 む組成物と、視神経乳頭に対する前記薬剤の 送達を増大させるための生理学上許容可能なプロスタグランジン又はプロスタグ ランジン誘導体を眼科的に許容可能な担体中に含む組成物とから成る調剤キット 。 6. 眼科的に許容可能な担体中に、視神経乳頭とその周囲領域との治療のため の有効量の薬剤と、視神経乳頭に対する前記薬剤の送達を増大させるための生理 学上許容可能なプロスタグランジン又はプロスタグランジン誘導体とを含む調剤 組成物。 7. 眼内の視神経乳頭領域における疾病の治療のための組成物を製造するため の、視神経乳頭の治療のための薬剤と、視神経乳頭に対する前記薬剤の送達を増 大させるための生理学上許容可能なプロスタグランジン又はプロスタグランジン 誘導体との使用。 8. 前記プロスタグランジンがPGF2 α類である請求項7に記載の使用。 9. 前記プロスタグランジンがエステルである請求項8に記載の使用。 10. 前記プロスタグランジン誘導体が13,14−ジヒドロ−17−フェニ ル−18,19,20−トリノル−PGF2 α−イソプロピルエステルである請 求項9に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402816A SE9402816D0 (sv) | 1994-08-24 | 1994-08-24 | Method and meams for drug administration |
SE9402816-4 | 1994-08-24 | ||
PCT/SE1995/000962 WO1996005840A1 (en) | 1994-08-24 | 1995-08-24 | Methods and means for drug administration |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10507743A true JPH10507743A (ja) | 1998-07-28 |
Family
ID=20395002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8508010A Expired - Lifetime JPH10507743A (ja) | 1994-08-24 | 1995-08-24 | 薬剤投与のための方法と手段 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5952378A (ja) |
EP (1) | EP0777483B1 (ja) |
JP (1) | JPH10507743A (ja) |
AT (1) | ATE238799T1 (ja) |
AU (1) | AU3402295A (ja) |
CA (1) | CA2198245C (ja) |
DE (1) | DE69530594T2 (ja) |
DK (1) | DK0777483T3 (ja) |
ES (1) | ES2199253T3 (ja) |
PT (1) | PT777483E (ja) |
SE (1) | SE9402816D0 (ja) |
WO (1) | WO1996005840A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007504198A (ja) * | 2003-09-05 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | ベンゾ[g]キノリン誘導体とプロスタグランジン誘導体を含む、組成物 |
JP2007513948A (ja) * | 2003-12-11 | 2007-05-31 | アルコン,インコーポレイテッド | 視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物 |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
AU2002258754B2 (en) | 2001-04-07 | 2006-08-17 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
WO2002085248A2 (en) * | 2001-04-23 | 2002-10-31 | Board Of Regents The University Of Texas System | Prostanoids augment ocular drug penetration |
US7678065B2 (en) | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
US7094225B2 (en) | 2001-05-03 | 2006-08-22 | Glaukos Corporation | Medical device and methods of use of glaucoma treatment |
WO2003004058A1 (en) * | 2001-07-02 | 2003-01-16 | Santen Pharmaceutical Co., Ltd. | OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT |
US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
US7163543B2 (en) * | 2001-11-08 | 2007-01-16 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
CN1620325A (zh) | 2001-12-14 | 2005-05-25 | 艾尔科公司 | 治疗眼睛障碍和疾病的超氧化物歧化酶模拟物 |
US20030113270A1 (en) * | 2001-12-14 | 2003-06-19 | Clark Abbot F. | Vasoactive intestinal peptides for glaucomatous retinopathy |
US7951155B2 (en) | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
EP1539066B1 (en) * | 2002-09-17 | 2012-11-07 | Iscience Surgical Corporation | Apparatus surgical bypass of aqueous humor |
TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
CA2564806A1 (en) * | 2004-04-29 | 2005-11-17 | Iscience Surgical Corporation | Apparatus and method for surgical enhancement of aqueous humor drainage |
US8322350B2 (en) | 2004-12-30 | 2012-12-04 | Philip Morris Usa Inc. | Aerosol generator |
WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
WO2007101204A1 (en) * | 2006-02-27 | 2007-09-07 | Alcon Research, Ltd. | Method of treating glaucoma |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
WO2009032273A1 (en) * | 2007-09-05 | 2009-03-12 | Teva Pharmaceutical Industries, Ltd. | Method of treating glaucoma using rasagiline |
US8425473B2 (en) | 2009-01-23 | 2013-04-23 | Iscience Interventional Corporation | Subretinal access device |
US20100191177A1 (en) * | 2009-01-23 | 2010-07-29 | Iscience Interventional Corporation | Device for aspirating fluids |
JP5342301B2 (ja) * | 2009-03-30 | 2013-11-13 | 三菱重工業株式会社 | 太陽光集光受熱器 |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
CN104758118B (zh) | 2010-10-15 | 2018-04-06 | 科尼尔赛德生物医学公司 | 用于进入眼睛的装置 |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP4193907A1 (en) | 2011-09-13 | 2023-06-14 | Glaukos Corporation | Intraocular physiological sensor |
CN104884049A (zh) | 2012-11-08 | 2015-09-02 | 克莱尔塞德生物医学股份有限公司 | 用于在人类受试者中治疗眼部疾病的方法和装置 |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
EP4378444A2 (en) | 2013-05-03 | 2024-06-05 | Clearside Biomedical, Inc. | Apparatus and methods for ocular injection |
EP3003454B1 (en) | 2013-06-03 | 2020-01-08 | Clearside Biomedical, Inc. | Apparatus for drug delivery using multiple reservoirs |
US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
EP3677229A1 (en) | 2014-05-29 | 2020-07-08 | Glaukos Corporation | Implants with controlled drug delivery features |
JP2017524419A (ja) | 2014-06-20 | 2017-08-31 | クリアサイド バイオメディカル,インコーポレイテッド | 薬剤送達のための挿入深さを制御するための可変径カニューレ及び方法 |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
EP3413851B1 (en) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Packaging |
JP7003110B2 (ja) | 2016-04-20 | 2022-01-20 | ドーズ メディカル コーポレーション | 生体吸収性眼球薬物送達デバイス |
CA3062845A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0286903B2 (en) * | 1987-04-03 | 2000-03-29 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
-
1994
- 1994-08-24 SE SE9402816A patent/SE9402816D0/xx unknown
-
1995
- 1995-08-24 DK DK95930761T patent/DK0777483T3/da active
- 1995-08-24 PT PT95930761T patent/PT777483E/pt unknown
- 1995-08-24 AT AT95930761T patent/ATE238799T1/de not_active IP Right Cessation
- 1995-08-24 WO PCT/SE1995/000962 patent/WO1996005840A1/en active IP Right Grant
- 1995-08-24 CA CA002198245A patent/CA2198245C/en not_active Expired - Fee Related
- 1995-08-24 EP EP95930761A patent/EP0777483B1/en not_active Expired - Lifetime
- 1995-08-24 ES ES95930761T patent/ES2199253T3/es not_active Expired - Lifetime
- 1995-08-24 AU AU34022/95A patent/AU3402295A/en not_active Abandoned
- 1995-08-24 DE DE69530594T patent/DE69530594T2/de not_active Expired - Fee Related
- 1995-08-24 JP JP8508010A patent/JPH10507743A/ja not_active Expired - Lifetime
- 1995-08-24 US US08/793,043 patent/US5952378A/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007504198A (ja) * | 2003-09-05 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | ベンゾ[g]キノリン誘導体とプロスタグランジン誘導体を含む、組成物 |
JP2007513948A (ja) * | 2003-12-11 | 2007-05-31 | アルコン,インコーポレイテッド | 視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物 |
Also Published As
Publication number | Publication date |
---|---|
PT777483E (pt) | 2003-09-30 |
EP0777483B1 (en) | 2003-05-02 |
DK0777483T3 (da) | 2003-08-25 |
ATE238799T1 (de) | 2003-05-15 |
EP0777483A1 (en) | 1997-06-11 |
US5952378A (en) | 1999-09-14 |
SE9402816D0 (sv) | 1994-08-24 |
DE69530594D1 (de) | 2003-06-05 |
AU3402295A (en) | 1996-03-14 |
CA2198245C (en) | 2003-06-17 |
DE69530594T2 (de) | 2004-03-18 |
CA2198245A1 (en) | 1996-02-29 |
WO1996005840A1 (en) | 1996-02-29 |
ES2199253T3 (es) | 2004-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10507743A (ja) | 薬剤投与のための方法と手段 | |
US6225348B1 (en) | Method of treating macular degeneration with a prostaglandin derivative | |
ES2363077T3 (es) | Composiciones lípido hopotensor (prostaglandinas) y timolol y procedimiento de uso de las mismas. | |
EP0093380B1 (en) | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma | |
JP2726672B2 (ja) | プロスタグランジンとアドレナリン性遮断剤との組合せからなる眼圧降下用組成物 | |
EP1003530A1 (en) | Eye treatments using synthetic thyroid hormone compositions | |
WO1989010757A1 (en) | New ophthalmic preparation for treating glaucoma | |
Hejkal et al. | Prostaglandin analogs in the treatment of glaucoma | |
US20120196937A1 (en) | Treatment of ophthalmic disorders using urea | |
Scherer et al. | Effect of latanoprost on intraocular pressure following cataract extraction | |
JPH08503968A (ja) | 増殖因子と代謝拮抗物質を含有する組成物 | |
WO2000021531A1 (fr) | Medicaments pour maladies oculaires | |
KR100854058B1 (ko) | 스테로이드를 유효 성분으로 하는 망맥락막 질환 치료제 | |
Sorbera et al. | Bimatoprost | |
RU2339369C2 (ru) | Лечение офтальмологических нарушений с использованием мочевины и ее производных | |
JP2004331502A (ja) | 視神経細胞保護剤 | |
JP4150846B2 (ja) | ステロイドを有効成分とする網脈絡膜疾患治療剤 | |
US20040259844A1 (en) | Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage | |
EP1161245B1 (en) | Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula | |
JP2002154985A (ja) | 眼疾患治療剤 | |
CA2398900A1 (en) | Therapeutic agents for opthalmopathy | |
Wyse et al. | Topical Prostaglandins for Galucoma Therapy | |
CN116898800A (zh) | 无防腐剂的眼科药物乳剂及其应用 | |
JP2004250347A (ja) | 網膜虚血に基づく疾患の治療および/又は予防剤 | |
JP2004537533A (ja) | 視神経細胞保護剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S803 | Written request for registration of cancellation of provisional registration |
Free format text: JAPANESE INTERMEDIATE CODE: R316805 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S803 | Written request for registration of cancellation of provisional registration |
Free format text: JAPANESE INTERMEDIATE CODE: R316805 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070905 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080905 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090905 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090905 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100905 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110905 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120905 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130905 Year of fee payment: 16 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |